Page 5 - Aptose Biosciences Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aptose biosciences company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aptose Biosciences Company Profile Today - Breaking & Trending Today

Aptose Biosciences (NASDAQ:APTO) Now Covered by StockNews.com

StockNews.com began coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Rating) (TSE:APS) in a report released on Tuesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. A number of other equities analysts have also recently weighed in on APTO. Cantor Fitzgerald upped their price target on Aptose Biosciences from $6.00 […] ....

Aptose Biosciences , Piper Sandler , Sequoia Financial Advisors , Toronto Dominion Bank , Aptose Biosciences Company Profile , Canaccord Genuity Group , Cantor Fitzgerald , Renaissance Technologies , Annandale Capital , Royal Bank , Sigma Planning Corp , Aptose Biosciences Inc , Get Rating , Biosciences Stock Down , Financial Advisors , Dominion Bank , Planning Corp , Biosciences Inc , Aptose Biosciences Daily ,

Aptose Biosciences (NASDAQ:APTO) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Rating) (TSE:APS) in a research report report published on Tuesday morning. The firm issued a hold rating on the biotechnology company’s stock. A number of other equities research analysts have also recently commented on APTO. Royal Bank of Canada lowered their target price on […] ....

Piper Sandler , Aptose Biosciences , Callan Capital , Aptose Biosciences Inc , Royal Bank , Cantor Fitzgerald , Canaccord Genuity Group , Formidable Asset Management , Aptose Biosciences Company Profile , Toronto Dominion Bank , Sequoia Financial Advisors , Cetera Advisors , Get Rating , Dominion Bank , Financial Advisors , Asset Management , Biosciences Inc , Aptose Biosciences Daily ,

Aptose Biosciences (NASDAQ:APTO) Price Target Increased to $50.00 by Analysts at Oppenheimer

Aptose Biosciences (NASDAQ:APTO – Get Rating) (TSE:APS) had its target price boosted by Oppenheimer from $9.00 to $50.00 in a report released on Monday morning, The Fly reports. APTO has been the topic of several other research reports. Royal Bank of Canada reduced their target price on shares of Aptose Biosciences from $75.00 to $40.00 […] ....

Piper Sandler , Aptose Biosciences , Royal Bank , Aptose Biosciences Inc , Sigma Planning Corp , Cetera Advisors , Millennium Management , Annandale Capital , Aptose Biosciences Company Profile , Canaccord Genuity Group , Get Rating , Genuity Group , Planning Corp , Biosciences Inc , Aptose Biosciences Daily ,

Aptose Biosciences (NASDAQ:APTO) PT Lowered to $40.00 at Royal Bank of Canada

Aptose Biosciences (NASDAQ:APTO – Get Rating) (TSE:APS) had its price target lowered by Royal Bank of Canada from $75.00 to $40.00 in a research report report published on Wednesday, The Fly reports. Several other research analysts have also weighed in on the stock. StockNews.com began coverage on shares of Aptose Biosciences in a research note […] ....

Aptose Biosciences , Piper Sandler , Sequoia Financial Advisors , Annandale Capital , Aptose Biosciences Inc , Aptose Biosciences Company Profile , Renaissance Technologies , Sigma Planning Corp , Canaccord Genuity Group , Toronto Dominion Bank , Royal Bank , Get Rating , Genuity Group , Financial Advisors , Dominion Bank , Planning Corp , Biosciences Inc , Aptose Biosciences Daily , Nasdaq Apto , Lower Price Target , Royal Bank Of Canada ,

Piper Sandler Cuts Aptose Biosciences (NASDAQ:APTO) Price Target to $37.00

Aptose Biosciences (NASDAQ:APTO – Get Rating) (TSE:APS) had its price target trimmed by Piper Sandler from $45.00 to $37.00 in a research report report published on Wednesday, The Fly reports. A number of other research analysts also recently weighed in on the stock. Royal Bank of Canada reaffirmed an outperform rating and issued a $75.00 […] ....

Piper Sandler , Aptose Biosciences , Formidable Asset Management , Aptose Biosciences Company Profile , Royal Bank , Cetera Advisors , Toronto Dominion Bank , Canaccord Genuity Group , Sequoia Financial Advisors , Callan Capital , Aptose Biosciences Inc , Get Rating , Genuity Group , Dominion Bank , Financial Advisors , Asset Management , Biosciences Inc , Aptose Biosciences Daily ,